BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 22, 2004
View Archived Issues
New data on AVP-893, a prototype of a novel class of antitumor agents from Avanir
Read More
Microtubule stabilizing agent potentiates anticancer activity in vitro
Read More
Significant prostate function improvements induced by an isoflavone red clover extract
Read More
Effective prevention of CINV with palonosetron before cisplatin-based chemotherapy
Read More
Therapeutic benefits of rosiglitazone in women with polycystic ovary syndrome
Read More
Improved safety profile of pegylated liposomal doxorubicin in metastatic breast cancer
Read More
R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: BioVex
Read More
R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: Concurrent
Read More
R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: Cytopia
Read More
PAI-1 inhibitors designed and synthesized at Wyeth
Read More
Pyridine acetic acids developed as potent, orally active and selective aldose reductase inhibitors
Read More
Janssen claims new alphav integrin inhibitors and their use in cancer, osteoporosis, etc.
Read More
Three series of telomerase inhibitors described by researchers at Mitsui Chemicals
Read More
De Novo presents two series of beta-secretase inhibitors and their use in AD therapy
Read More
Novel proline-based antibacterial agents in early development at Dainippon
Read More
Dual PPARalpha/PPARgamma agonists designed at Roche
Read More
AstraZeneca patent covers dual NK1 antagonists/5-HT reuptake inhibitors and their use
Read More
PEDESTAL trial evaluates alagebrium for diastolic dysfunction
Read More
IR-103 shows HIV-1 specific immunogenicity in mouse model
Read More
Alovudine enters dose-finding phase IIa study in multiresistant HIV
Read More
Roche and Isotechnika restructure ISA-247 collaboration agreement
Read More
Apidra receives FDA approval
Read More
Private placement financing ensures progress of AEOL-10150 into clinic
Read More
Orphan medicinal product status for CA4P for anaplastic thyroid cancer
Read More
CT-2106 enters phase I/II trial for colorectal cancer
Read More
New preclinical data reported for MPC-4505
Read More
Phase II trial of MPC-7869 progresses on schedule
Read More
Bristol-Myers Squibb receives North American and Asian license for Javlor
Read More
Phase III program commences for Xerecept in peritumoral cerebral edema
Read More
Genasense available through Expanded Access Program for advanced melanoma
Read More
Phase II trial under way for R-112 in allergic rhinitis
Read More